Screening and surveillance in Barrett's esophagus: A call to action

Clinical Gastroenterology and Hepatology

Volumn 2, Issue 10, 2004, Pages 861-864

  Eisen, Glenn M ^a   Lieberman, David ^a   Fennerty, M Brian ^a   Sonnenberg, Amnon ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER SCREENING; CAUSE OF DEATH; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; EDITORIAL; ENDOSCOPIC BIOPSY; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; HEALTH INSURANCE; HUMAN; PREVALENCE; RISK FACTOR; TOBACCO DEPENDENCE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; COST-BENEFIT ANALYSIS; EARLY DIAGNOSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; MASS SCREENING; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; PRECANCEROUS CONDITIONS; UNITED STATES;

EID: 5044225773     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00388-X     Document Type: Editorial

References (30)

1. R.E. Sampliner Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 97 2002 1888 1895
2. D.L. Sackett S.E. Straus W.S. Richardson W. Rosenberg R.B. Haynes Evidence-based medicine 2nd edition 2000 Churchill Livingstone New York
3. N. Shaheen, D.F. Ransohoff Gastroesophageal reflux, Barrett esophagus and esophageal cancer scientific review JAMA 287 2002 1972 1981
4. G.W. Falk Barrett's esophagus Gastroenterology 122 2002 1569 1591
5. C. Winters, T.J. Spurling, S.J. Chobanian, D.J. Curtis, R.L. Esposito, J.F. Hacker III, D.A. Johnson, D.F. Cruess, J.D. Cotelingam, M.S. Gurney Barrett's esophagus a prevalent occult complication of gastroesophageal reflux disease Gastroenterology 92 1987 118 124
6. D.A. Lieberman, M. Oehlke, M. Helfand GORGE consortium Risk factors for Barrett's esophagus in community-based practice Am J Gastroenterol 92 1997 1293 1297
7. G.M. Eisen, R.S. Sandler, S. Murray, M. Gottfried The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus Am J Gastroenterol 92 1997 27 31
8. L.B. Gerson, K. Shetler, G. Triadafilopoulos Prevalence of Barrett's esophagus in asymptomatic individuals Gastroenterology 123 2002 461 467
9. A.J. Cameron, A.R. Zinsmeister, D.J. Ballard, J.A. Carney Prevalence of columnar-lined (Barrett's) esophagus comparison of population-based clinical and autopsy findings Gastroenterology 99 1990 918 922
10. M. Conio, A.J. Cameron, Y. Romero, C.D. Branch, C.D. Schleck, L.J. Burgart, A.R. Zinsmeister, L.J. Melton, G.R. Locke Secular tends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota Gut 48 2001 304 309
11. J. Lagergren, R. Bergstrom, A. Lindren, O. Nyren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831
12. W.H. Chow, W.D. Finkle, J.K. McLaughlin, H. Frankl, H.K. Ziel, J.F. Fraument Jr The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia JAMA 274 1995 474 477
13. D.C. Farrow, T.L. Vaughan, C. Sweeney, M.D. Gammon, W.H. Chow, H.A. Risch, J.L. Stanford, P.D. Hantsen, S.T. Mayne, J.B. Schoenberg, H. Rotterdam, H. Ahsan, A.B. West, R. Dubrow, J.F. Fraumeni, W.J. Blot Gastroesophageal reflux disease, use of H2 receptor antagonists and risk of esophageal and gastric cancer Cancer Causes Control 11 2000 231 238
14. N.J. Shaheen, M.A. Crosby, E.M. Bozymski, R.S. Sandler Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119 2000 333 338
15. B.J. Reid, D.S. Levine, G. Longton, P.L. Blount, P.S. Rabinovitich Predictors of progression to cancer in Barrett's esophagus baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol 95 2000 1669 1676
16. N.S. Buttar, K.K. Wang, T.J. Sebo, D.M. Riehle, K.K. Krishnaduth, L.S. Lutzke, M.A. Anderson, T.M. Petterson, L.J. Burgart Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma Gastroenterology 120 2001 1630 1639
17. T.G. Schnell, S.J. Sontag, G. Chejfec, G. Aranha, A. Metz, S. O'Connell, U.J. Seidel, A. Sonnenberg Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 2001 1607 1619
18. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, M.J. Thun Cancer statistics 2003 CA Cancer J Clin 53 2003 5 26
19. D.A. Corley, T.R. Levin, L.A. Habel, N.S. Weiss, P.A. Buffler Surveillance and survival in Barrett's adenocarcinomas a population-based study Gastroenterology 122 2002 633 640
20. G.S. Dulai, S. Guha, K.L. Kahn, J. Gornbein, W.M. Weinstein Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma a systematic review Gastroenterology 122 2002 26 33
21. J.M. Inadomi, R. Sampliner, J. Lagergren, D. Lieberman, A.M. Fendrick, N. Vakil Screening and surveillance for Barrett's esophagus in high-risk populations a cost-utility analysis Ann Intern Med 138 2003 176 186
22. A. Soni, R.E. Sampliner, A. Sonnenber Screening for high-grade dysplasia in gastroesophageal reflux disease is it cost-effective Am J Gastroenterol 95 2000 2086 2093
23. L.A. Anderson, L.J. Murray, S.J. Murphy, D.A. Fitzpatrick, B.T. Johnston, R.GP. Watson, P. McCarron, A.T. Gavin Mortality in Barrett's oesophagus results from a population based study Gut 52 2003 1081 1084
24. D. Provenzale, C. Schmitt, J.B. Wong Barrett's esophagus a new look at surveillance based on emerging estimates of cancer risk Am J Gastroenterol 94 1999 2043 2053
25. D.A. Corley, K. Kerlikowske, R. Verma, P. Buffler Protective association of aspirin/NSAIDs and esophageal cancer a systematic review and meta-analysis Gastroenterology 124 2003 47 56
26. M.B. Fennerty Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression? Rev Gastroenterol Disord 2 suppl 2 2002 S30 S37
27. L.A. Anderson, L.J. Murray, S.J. Murphy, D.A. Fitzpatrick, B.T. Johnston, R.G. Watson, P. McCarron, A.T. Gavin Mortality in Barrett's oesophagus results from a population based study Gut 52 2003 1081 1084
28. M.A. Eloubedi, D. Provenzale Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease without Barrett's esophagus Am J Gastroenterol 95 2000 1881 1887
29. Shaheen NJ, Ascher B, Schmitz SM. How much does a diagnosis of Barrett's esophagus raise insurance premiums? Am J Gastroenterol;98(suppl):A670.
30. L.B. Gerson, P.W. Groeneveld, G. Triadafilopoulos A model of cost-effectiveness of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2 2004 868 879